Efficacy of beta-blockade after isolated blunt head injury: Does race matter?

Journal of Trauma and Acute Care Surgery

Volumn 72, Issue 4, 2012, Pages 1013-1018

  Bukur, Marko ^a   Mosheni, Shahin ^b   Ley, Eric ^a   Salim, Ali ^a   Margulies, Daniel ^a   Talving, Peep ^b   Demetriades, Demetrios ^b   Inaba, Kenji ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

Beta blocker; Ethnicity; Head injury; Mortality; Trauma

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; BLUNT TRAUMA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRANIECTOMY; CRANIOTOMY; DEMOGRAPHY; DISEASE REGISTRY; DISEASE SEVERITY; ETHNICITY; FEMALE; HEAD INJURY; HUMAN; INTENSIVE CARE UNIT; ISOLATED BLUNT HEAD INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; RETROSPECTIVE STUDY; TRAUMATIC BRAIN INJURY; ASIAN AMERICAN; CAUCASIAN; EMERGENCY HEALTH SERVICE; HISPANIC; INJURY SCALE; MIDDLE AGED; NEGRO; RACE; REGRESSION ANALYSIS; STATISTICS; TREATMENT OUTCOME; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN AMERICANS; CALIFORNIA; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEAD INJURIES, CLOSED; HISPANIC AMERICANS; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TRAUMA CENTERS; TREATMENT OUTCOME;

EID: 84862741513     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e318241bc5b     Document Type: Article

References (54)

1. Shackford SR, Mackersie RC, Holbrook TL, et al. The epidemiology of traumatic death. A population-based analysis. Arch Surg. 1993;128:571-575.
2. Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006;21:375-378.
3. Acosta JA, Yang JC, Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg. 1998;186:528-533.
4. Corrigan JD, Selassie AW, Orman JA. The epidemiology of traumatic brain injury. J Head Trauma Rehabil. 2010;25:72-80.
5. Maas AI, Marmarou A, Murray GD, Teasdale SG, Steyerberg EW. Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J Neurotrauma. 2007;24:232-238.
6. Mosenthal AC, Livingston DH, Lavery RF, et al. The effect of age on functional outcome in mild traumatic brain injury: 6-month report of a prospective multicenter trial. J Trauma. 2004;56:1042-1048.
7. Munro PT, Smith RD, Parke TR. Effect of patients' age on management of acute intracranial haematoma: prospective national study. BMJ. 2002; 325:1001.
8. Groswasser Z, Cohen M, Keren O. Female TBI patients recover better than males. Brain Inj. 1998;12:805-808.
9. Davis DP, Serrano JA, Vilke GM, et al. The predictive value of field versus arrival Glasgow Coma Scale score and TRISS calculations in moderate-to-severe traumatic brain injury. J Trauma. 2006;60:985-990.
10. Smits M, Dippel DW, de Haan GG, et al. External validation of the Canadian CT Head Rule and the New Orleans Criteria for CT scanning in patients with minor head injury. JAMA. 2005;294:1519-1525.
11. Teasdale G, Jennett B. Assessment and prognosis of coma after head injury. Acta Neurochir (Wien). 1976;34:45-55.
12. Heffernan DS, Inaba K, Arbabi S, Cotton BA. Sympathetic hyperactivity after traumatic brain injury and the role of beta-blocker therapy. J Trauma. 2010;69:1602-1609.
13. Kemp CD, Johnson JC, Riordan WP, Cotton BA. How we die: the impact of nonneurologic organ dysfunction after severe traumatic brain injury. Am Surg. 2008;74:866-872.
14. Zygun DA, Kortbeek JB, Fick GH, Laupland KB, Doig CJ. Nonneurologic organ dysfunction in severe traumatic brain injury. Crit Care Med. 2005;33:654-660.
15. Woolf PD, McDonald JV, Feliciano DV, Kelly MM, Nichols D, Cox C. The catecholamine response to multisystem trauma. Arch Surg. 1992; 127:899-903.
16. Liu MY. Protective effects of propranolol on experimentally headinjured mouse brains. J Formos Med Assoc. 1995;94:386-390.
17. Ley EJ, Scehnet J, Park R, et al. The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. J Trauma. 2009;66:154-159; discussion 159-161.
18. Ley EJ, Park R, Dagliyan G, et al. In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury. J Trauma. 2010;68:353-356.
19. Arbabi S, Campion EM, Hemmila MR, et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma. 2007;62:56-61; discussion 61-62.
20. Cotton BA, Snodgrass KB, Fleming SB, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007;62:26-33, discussion 33-35.
21. Inaba K, Teixeira PG, David JS, et al. Beta-blockers in isolated blunt head injury. J Am Coll Surg. 2008;206:432-438.
22. Schroeppel TJ, Fischer PE, Zarzaur BL, et al. Beta-adrenergic blockade and traumatic brain injury: protective? J Trauma. 2010;69:776-782.
23. Haider AH, Efron DT, Haut ER, DiRusso SM, Sullivan T, Cornwell EE III. Black children experience worse clinical and functional outcomes after traumatic brain injury: an analysis of the National Pediatric Trauma Registry. J Trauma. 2007;62:1259-1262; discussion 1262-1263.
24. Gary KW, Arango-Lasprilla JC, Stevens LF. Do racial/ethnic differences exist in post-injury outcomes after TBI? A comprehensive review of the literature. Brain Inj. 2009;23:775-789.
25. Berry C, Ley EJ, Mirocha J, Salim A. Race affects mortality after moderate to severe traumatic brain injury. J Surg Res. 2010;163:303-308.
26. DeKosky ST, Ikonomovic MD, Gandy S. Traumatic brain injury - football, warfare, and long-term effects. N Engl J Med. 2010;363:1293-1296.
27. Arbabi S, Ahrns KS, Wahl WL, et al. Beta-blocker use is associated with improved outcomes in adult burn patients. J Trauma. 2004;56:265-269; discussion 269-271.
28. Meyer JS, Miyakawa Y, Welch KM, et al. Influence of adrenergic receptor blockade on circulatory and metabolic effects of disordered neurotransmitter function in stroke patients. Stroke. 1976;7:158-167.
29. Alexander RW, Davis JN, Lefkowitz RJ. Direct identification and characterisation of beta-adrenergic receptors in rat brain. Nature. 1975; 258:437-440.
30. MacKenzie ET, McCulloch J, Harper AM. Influence of endogenous norepinephrine on cerebral blood flow and metabolism. Am J Physiol. 1976;231:489-494.
31. Hawkins WE, Clower BR. Myocardial damage after head trauma and simulated intracranial haemorrhage in mice: the role of the autonomic nervous system. Cardiovasc Res. 1971;5:524-529.
32. Connor RC. Myocardial damage secondary to brain lesions. Am Heart J. 1969;78:145-148.
33. Colgan FJ, Sawa T, Teneyck LG, Izzo JL Jr. Protective effects of beta blockade on pulmonary function when intracranial pressure is elevated. Crit Care Med. 1983;11:368-372.
34. Jordan BD. Genetic influences on outcome following traumatic brain injury. Neurochem Res. 2007;32:905-915.
35. Collins FS. What we do and don't know about 'race,' 'ethnicity,' genetics and health at the dawn of the genome era. Nat Genet. 2004; 36(11 suppl):S13-S15.
36. Kraus JF, Fife D, Ramstein K, Conroy C, Cox P. The relationship of family income to the incidence, external causes, and outcomes of serious brain injury, San Diego County, California. Am J Public Health. 1986; 76:1345-1347.
37. Sorani MD, Lee M, Kim H, Meeker M, Manley GT. Race/ethnicity and outcome after traumatic brain injury at a single, diverse center. J Trauma. 2009;67:75-80.
38. Jager TE, Weiss HB, Coben JH, Pepe PE. Traumatic brain injuries evaluated in U.S. emergency departments, 1992-1994. Acad Emerg Med. 2000;7:134-140.
39. Bowman SM, Martin DP, Sharar SR, Zimmerman FJ. Racial disparities in outcomes of persons with moderate to severe traumatic brain injury. Med Care. 2007;45:686-690.
40. Gillum RF. Pathophysiology of hypertension in blacks and whites. A review of the basis of racial blood pressure differences. Hypertension. 1979;1:468-475.
41. Yancy CW. Does race matter in heart failure? Am Heart J. 2003;146: 203-206.
42. Dries DL, Exner DV, Gersh BJ, Cooper HA, Carson PE, Domanski MJ. Racial differences in the outcome of left ventricular dysfunction. N Engl J Med. 1999;340:609-616.
43. Taylor AL, Ziesche S, Yancy C, et al; African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351: 2049-2057.
44. Bloche MG. Race-based therapeutics. N Engl J Med. 2004;351:2035-2037.
45. Lipsky RH, Goldman D. Genomics and variation of ionotropic glutamate receptors. Ann N Y Acad Sci. 2003;1003:22-35.
46. Han RQ, Ouyang YB, Xu L, Agrawal R, Patterson AJ, Giffard RG. Postischemic brain injury is attenuated in mice lacking the beta2-adrenergic receptor. Anesth Analg. 2009;108:280-287.
47. Ray SK, Dixon CE, Banik NL. Molecular mechanisms in the pathogenesis of traumatic brain injury. Histol Histopathol. 2002;17:1137-1152.
48. Chen Y, Lomnitski L, Michaelson DM, Shohami E. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience. 1997;80:1255-1262.
49. McAllister TW. Genetic factors modulating outcome after neurotrauma. PM R. 2010;2(12 suppl 2):S241-S252.
50. Cacioppo JT, Hawkley LC. Social isolation and health, with an emphasis on underlying mechanisms. Perspect Biol Med. 2003;46(3 suppl):S39-S52.
51. Girasek DC, Taylor B. An exploratory study of the relationship between socioeconomic status and motor vehicle safety features. Traffic Inj Prev. 2010;11:151-155.
52. Voas RB, Romano E, Peck R. Validity of surrogate measures of alcohol involvement when applied to nonfatal crashes. Accid Anal Prev. 2009;41:522-530.
53. McEwen BS. Understanding the potency of stressful early life experiences on brain and body function. Metabolism. 2008;57 suppl 2:S11-S15.
54. McEwen BS. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008;583:174-185.